Back to Agenda
Session 5B: Regulatory Agencies Perspective on Biotherapeutics & Biosimilar Products
Session Chair(s)
Hans Vasquez, MD, MPH
Director for Research and Technology Transfer
Peruvian National Institute of Health, Peru
Session 5B: Regulatory Agencies Perspective on Biotherapeutics & Biosimilar Products
Speaker(s)
Introduction
Hans Vasquez, MD, MPH
Peruvian National Institute of Health, Peru
Director for Research and Technology Transfer
Argentinean Perspective
Patricia Aprea, MD
ANMAT, Argentina
Director, Evaluation and Control of Biológicals/Research
Brazillian Perspective
Silmara Cristiane da Silveira Andreoli
ANVISA, Brazil
Especialista em Regulação e Vigilância Sanitária
Mexican Perspective
Francisco García Zetina
COFEPRIS, Mexico
Director Ejecutivo De Autorización de Productos y Establecimientos
Columbian Perspective (via TC)
Claudia Vaca, MD
Ministry of Public Health and Social Protection, Colombia
Senior Advisor, Medicines
Interactive Discussions with Panelists and Audience
Thomas Kirchlechner, PhD
Sandoz Biopharmaceuticals Development (Novartis), Austria
Head, Regulatory Emerging Markets
Interactive Discussions with Panelists and Audience
Hans Vasquez, MD, MPH
Peruvian National Institute of Health, Peru
Director for Research and Technology Transfer
Have an account?